Explore Stanford technologies available for licensing:

Researchers at Stanford are advancing a new paradigm in rheological measurement.

Stanford doctors have developed a retractor that easily and accurately measures orbital compartment pressure without requiring precise orientation to the central cornea.

The potency of cancer immunotherapies for solid tumors are often diminished by inadequate metabolic reprogramming and resulting immune evasion in cancer.

Researchers in the Mackall lab at Stanford have developed an adoptive cell therapy modification that enhances anti-tumor activity by disrupting a specific group of genes.

Researchers in the Molecular Imaging Instrumentation Laboratory at Stanford University have developed a PET (positron emission tomography) detector and front end readout assembly that can operate in a high field MRI (magnetic resonance imaging) system.

Researchers at Stanford have developed the first known fixed-frequency control method to enable piezoelectric based power converters to avoid spurious mode and operate across a full output power range while maintaining high efficiency.

Inventors at Stanford developed a method to leverage mass cytometry, a type of flow cytometry utilizing mass spectrometry, for the detection of heavy metals in leukocytes from individuals exposed to heavy metals in elevated air pollution.

Researchers at Stanford have developed a method for instructing the steering system of an autonomous vehicle to perform a lateral steering action, e.g., when changing lanes or repositioning within a lane.

Researchers at Stanford University's Curtis Laboratory have used gene expression to categorize the sensitivity and resistance of anthracycline chemotherapy in breast cancer patients with utmost precision.

Researchers at Stanford have developed a method using expressed genetic barcodes to enable simultaneous lineage tracing and single cell profiling. Intratumor heterogeneity fosters tumor evolution which is a key contributor to therapeutic failure and the lethality of cancer.

Researchers at Stanford have leveraged spatial proteomic analysis to identify biomarkers with immediate implications for HER2-positive breast cancer treatment decision making and patient stratification.

Researchers at Stanford have developed a new synthetic strategy for self-assembling layered heterostructures into large single crystals and films useful in microelectronics.

We present a simple, and cost-effective ultrasound device for in-vitro neurostimulation to facilitate fundamental and advanced research in the field.

Researchers at Stanford University have developed a new medical device, MagSToNE (Magnetic System for Total Nephrolith Extraction), which utilizes magnetization to remove kidney stones during ureteroscopy to maximize the stone-free rate and minimize operating time.

Stanford inventors have developed and fabricated biodegradable and biocompatible polysaccharide hydrogel optical fibers for fiber optic sensing and light transmission in biomedical applications like antigen detection, tracking cellular events, and optogenetics.